Terms: = Breast cancer AND PRKACA, MGC48865, 5566, ENSG00000072062, P17612, PKACA, MGC102831 AND Treatment
4 results:
1. Stabilization of MORC2 by estrogen and antiestrogens through GPER1- prkaca-CMA pathway contributes to estrogen-induced proliferation and endocrine resistance of breast cancer cells.
Yang F; Xie HY; Yang LF; Zhang L; Zhang FL; Liu HY; Li DQ; Shao ZM
Autophagy; 2020 Jun; 16(6):1061-1076. PubMed ID: 32401166
[TBL] [Abstract] [Full Text] [Related]
2. Involvement of multiple cellular pathways in regulating resistance to tamoxifen in BIK-suppressed MCF-7 cells.
Viedma-Rodríguez R; Ruiz Esparza-Garrido R; Baiza-Gutman LA; Velázquez-Flores MÁ; García-Carrancá A; Salamanca-Gómez F; Arenas-Aranda D
Tumour Biol; 2015 Sep; 36(9):6991-7005. PubMed ID: 25861752
[TBL] [Abstract] [Full Text] [Related]
3. prkaca mediates resistance to HER2-targeted therapy in breast cancer cells and restores anti-apoptotic signaling.
Moody SE; Schinzel AC; Singh S; Izzo F; Strickland MR; Luo L; Thomas SR; Boehm JS; Kim SY; Wang ZC; Hahn WC
Oncogene; 2015 Apr; 34(16):2061-71. PubMed ID: 24909179
[TBL] [Abstract] [Full Text] [Related]
4. Association between LRRK2 and 4E-BP1 protein levels in normal and malignant cells.
Pons B; Armengol G; Livingstone M; López L; Coch L; Sonenberg N; Ramón y Cajal S
Oncol Rep; 2012 Jan; 27(1):225-31. PubMed ID: 21922152
[TBL] [Abstract] [Full Text] [Related]
